Literature DB >> 5008482

Folate deficiency after anticonvulsant drugs: an effect of hepatic enzyme induction?

J D Maxwell, J Hunter, D A Stewart, S Ardeman, R Williams.   

Abstract

Serum and red cell folate levels were reduced in 59% and 58% respectively of 75 children with epilepsy attending a residential school. The degree of folate deficiency was significantly related to increased hepatic microsomal enzyme activity, assessed from increased urinary excretion of D-glucaric acid and also correlated with the daily dose of anticonvulsant taken. Anticonvulsant drugs are known to have inducing properties, and since folate is required as a cofactor in drug hydroxylations it is suggested that folate depletion results from increased demand for the cofactor after induction of drug-metabolizing enzymes. As folate deficiency may ultimately limit drug metabolism this hypothesis would explain why blood phenytoin levels decrease and fit control may worsen after correction of folate deficiency in epileptic patients.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5008482      PMCID: PMC1787173          DOI: 10.1136/bmj.1.5795.297

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  29 in total

1.  STUDIES ON THE STRUCTURE OF THE PRIMARY OXIDATION PRODUCT FORMED FROM TETRAHYDROPTERIDINES DURING PHENYLALAMINE HYDROXYLATION.

Authors:  S KAUFMAN
Journal:  J Biol Chem       Date:  1964-01       Impact factor: 5.157

2.  Urinary D-glucaric-acid excretion as a test for hepatic enzyme induction in man.

Authors:  J Hunter; J D Maxwell; M Carrella; D A Stewart; R Williams
Journal:  Lancet       Date:  1971-03-20       Impact factor: 79.321

3.  Mechanism of folate deficiency in patients receiving phenytoin.

Authors:  A V Hoffbrand; T F Necheles
Journal:  Lancet       Date:  1968-09-07       Impact factor: 79.321

4.  Impairment of intestinal deconjugation of dietary folate. A possible explanation of megaloblastic anaemia associated with phenytoin therapy.

Authors:  I H Rosenberg; H A Godwin; R R Streiff; W B Castle
Journal:  Lancet       Date:  1968-09-07       Impact factor: 79.321

5.  Folic acid and anticonvulsants.

Authors:  N M Viukari
Journal:  Lancet       Date:  1968-05-04       Impact factor: 79.321

6.  Folic acid and anticonvulsants.

Authors:  E H Reynolds; J Preece; I Chanarin
Journal:  Lancet       Date:  1969-06-21       Impact factor: 79.321

7.  Jejunal pH and folic acid.

Authors:  W F Doe; A V Hoffbrand; P I Reed; J M Scott
Journal:  Br Med J       Date:  1971-03-20

8.  Alcoholism, alcohol, and drugs.

Authors:  E Rubin; C S Lieber
Journal:  Science       Date:  1971-06-11       Impact factor: 47.728

9.  Megaloblastic anaemia in anticonvulsant therapy.

Authors:  M J Meynell
Journal:  Lancet       Date:  1966-02-26       Impact factor: 79.321

10.  Osteomalacia with long-term anticonvulsant therapy in epilepsy.

Authors:  C E Dent; A Richens; D J Rowe; T C Stamp
Journal:  Br Med J       Date:  1970-10-10
View more
  26 in total

1.  The clinical consequences of chronic hepatic enzyme induction by anticonvulsant drugs.

Authors:  A Richens
Journal:  Br J Clin Pharmacol       Date:  1974-06       Impact factor: 4.335

2.  Urinary D-glucaric acid excretion and plasma antipyrine kinetics during enzyme induction.

Authors:  M Davis; C J Simmons; B Dordoni; R Williams
Journal:  Br J Clin Pharmacol       Date:  1974-06       Impact factor: 4.335

Review 3.  Drug metabolism and hepatotoxicity.

Authors:  J M Tredger; M Davis
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

4.  Effect of Folic Acid Supplementation on Seizure Control in Epileptic Children Receiving Long Term Antiepileptic Therapy.

Authors:  Bindu Deopa; Manish Parakh; Pawan Dara; Vikas Payal; Kapil Chordiya; Ankit Panday; Sumeet Singh; Devesh Parashar
Journal:  Indian J Pediatr       Date:  2018-01-25       Impact factor: 1.967

5.  The effects of chronic drug administration on hepatic enzyme induction and folate metabolism.

Authors:  D Labadarios; J W Dickerson; D V Parke; E G Lucas; G H Obuwa
Journal:  Br J Clin Pharmacol       Date:  1978-02       Impact factor: 4.335

6.  Lack of hepatic enzyme inducing effect of sodium valproate.

Authors:  J Oxley; A Hedges; K A Makki; A Monks; A Richens
Journal:  Br J Clin Pharmacol       Date:  1979-08       Impact factor: 4.335

Review 7.  Drugs and folate metabolism.

Authors:  D G Lambie; R H Johnson
Journal:  Drugs       Date:  1985-08       Impact factor: 9.546

8.  Effects of anticonvulsants and methotrexate on calcium disposition.

Authors:  M A Evans
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980       Impact factor: 3.000

Review 9.  Influence of diet and nutritional status on drug metabolism.

Authors:  I Walter-Sack; U Klotz
Journal:  Clin Pharmacokinet       Date:  1996-07       Impact factor: 6.447

10.  Folic acid and mental symptoms in children with epilepsy.

Authors:  M R Trimble; J A Corbett; D Donaldson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-11       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.